Cromos Pharma has extensive experience in cardiovascular and cardiometabolic space across the entire drug development spectrum
Despite the advances in the cardiometabolic field over the past 20 years, cardiovascular and metabolic diseases remain the leading causes of morbidity and mortality worldwide. The need to discover and develop better, safer, and more cost-effective drugs and devices remains.
Cromos Pharma has 19 years of experience conducting cardiovascular research with a particular emphasis on key cardiovascular and metabolic indications. We have both scientific and clinical expertise to support a wide array of cardiology studies, from early to late phase, and with single- or multi-country execution strategies. By leveraging our international expertise, we deliver unparallel results through diligent feasibility analysis, rapid startup and accelerated recruitment, while utilizing proactive risk management strategies and maintaining the highest data quality.
Our team has vast expertise in organizing scientific advisory board meetings of academic and clinical cardiologists and KOLs.